Laxter Pharmaceuticals Private Limited

Laxter Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U74999GJ2018PTC103970 Incorporated 07 September 2018 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Pending Strike Off Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹1.51 Cr
▼ 62% YoY
Net profit · FY 2023
₹54,930
Net margin 0.4%
EBITDA · FY 2023
₹3.52 Lakh
EBITDA margin 2.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Satisfied ₹1.4 Cr
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Laxter Pharmaceuticals Private Limited

Data last updated:

Laxter Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 September 2018.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC103970. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sagar Pravinbhai Hirani and Jagbir Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 22 Mahesh Tenaments Nr. Sahjanand Complex Nr. Holy – Child – Sch. Thakkarbapa, Ahmedabad, Gujarat, India – 382350.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.51 Cr, a decline of 62% compared to the previous year. For the same year it recorded a net profit of ₹54,930 (net margin 0.4%) and EBITDA of ₹3.52 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.

As per MCA filings, the company has open charges of ₹1.4 Cr and satisfied charges of ₹1.4 Cr on record.

The last known website on record is laxterpharma.com.

Company details

CIN U74999GJ2018PTC103970
Registration Number 103970
Incorporation Date 07 September 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Under Process of Striking Off
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Laxter Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is laxterpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    22 Mahesh Tenaments Nr. Sahjanand Complex Nr. Holy – Child – Sch. Thakkarbapa, Ahmedabad, Gujarat, India – 382350
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Laxter Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Laxter Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Laxter Pharmaceuticals Private Limited

FY 2025 filings available

Laxter Pharmaceuticals Private Limited reported revenue of ₹1.51 Cr (down 62% YoY) for FY 2023.

Revenue · FY 2023
₹1.51 Cr ▼ 62%
Net profit · FY 2023
₹54,930 margin 0.4%
EBITDA · FY 2023
₹3.52 Lakh margin 2.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 62%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 93%
3 years · compounded
▲ 32%

Revenue fell 62% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹1.51 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.52 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹54,930
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin2.3%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Laxter Pharmaceuticals Private Limited, buy the company report.

Board of directors of Laxter Pharmaceuticals Private Limited

Laxter Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sagar Pravinbhai HiraniDirector09 May 20197 Years 6 MonthsCurrent
Jagbir SinghDirector07 Sep 20188 Years 2 MonthsCurrent

Auditor

Laxter Pharmaceuticals Private Limited is audited by A. K. GAJERA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A. K. GAJERA & CO.FY 2023143126W

Shareholding

The shareholding of Laxter Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Laxter Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.4 Cr
Satisfied charges
₹1.4 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹1.40 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Nov 2021100505405Hdfc Bank Limited₹70 LakhSatisfied
08 Oct 2021100504504Hdfc Bank Limited₹70 LakhSatisfied

To see the full charge records of Laxter Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Laxter Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Laxter Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Laxter Pharmaceuticals Private Limited, buy the company report.

Recent activity

Laxter Pharmaceuticals Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Arti Gohel Jayendrabhai ceased to be Director on 31 Aug 2024.

Charges
A charge registered on 17 Nov 2021 via Charge ID 100505405 with Hdfc Bank Limited was fully satisfied on 29 Oct 2025.
Charges
A charge registered on 08 Oct 2021 via Charge ID 100504504 with Hdfc Bank Limited was fully satisfied on 29 Oct 2025.
AGM
Laxter Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laxter Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Arti Gohel Jayendrabhai ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 70.00 Lakh with Charge ID 100505405 was registered on 17 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 70.00 Lakh with Charge ID 100504504 was registered on 08 Oct 2021.
Ceased
Jagdish Pravinbhai Hirani ceased to be Director.
Ceased
Kuldeep Kanaiyalal Ribadiya ceased to be Director.
Ceased
Namankumar Kanubhai Trapsia ceased to be Director.
Ceased
Rushikumarkanaiyalal Ribadiya ceased to be Director.
Appointed
Sagar Pravinbhai Hirani was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Laxter Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.

Laxter Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 September 2018 and is registered under CIN U74999GJ2018PTC103970. The company may be struck off soon - caution is advised.

Laxter Pharmaceuticals has 2 current directors:

The CIN (Corporate Identification Number) of Laxter Pharmaceuticals is U74999GJ2018PTC103970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Laxter Pharmaceuticals was incorporated on 07 September 2018. It is registered with the Registrar of Companies, Ahmedabad.

Laxter Pharmaceuticals can be reached through the website laxterpharma.com. Its registered office is in Ahmedabad, Gujarat, India.

The registered office of Laxter Pharmaceuticals is at 22 Mahesh Tenaments Nr. Sahjanand Complex Nr. Holy – Child – Sch. Thakkarbapa, Ahmedabad, Gujarat, India – 382350.

The latest financial statements of Laxter Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

No. Laxter Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

Laxter Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.